肝门部海绵状血管瘤的动脉栓塞治疗

Treatment of hilar cavernous hemangiomas of the liver by hepatic arterial embolization

目的评价经肝动脉栓塞治疗肝门部附近海绵状血管瘤的疗效和价值。方法14例肝门部海绵状血管瘤使用平阳霉素碘化油乳剂+明胶教海绵颗粒经肝动脉栓塞,术后随访3～36月,观察栓塞前、后瘤体的变化,临床症状缓解情况。结果随访期间,14例临床症状明显缓解,瘤体均有不同程度的缩小,在术后12月CT复查时,瘤体直径由术前7.33±1.8cm缩小至3.5±1.7cm(P<0.05),无严重并发症。结论肝动脉栓塞术是治疗肝门部海绵状血管瘤的首选方法。

Objective To investigate the therapeutic effects of hepatic arterial embolization for hilar cavernous hemangiomas of the liver. Methods Fourteen cases of hilar cavernous hemangiomas of liver were treated with Pingyangmycin-lipiodol emulsion combined with gelatin particles by transcatheter hepatic arterial embolization. All cases were followed up for 3-36 months after procedures. The changes of cavernous hemangiomas and improvement of clinical signs were observed. Results During the period of follow-up, the cavernous hemangiomas were shrunk to varying agrees and symptoms alleviated in all cases. Twelve months after treatment, the size of cavernous hemangiomas was reduced from （7. 33 ± 1.8） cm to （3.5 ± 1.7） cm （P〈0. 05）. No serious complications occurred. Conclusion Transcatheter hepatic artery embolization with Pingyangmycin-lipiodol emulsion is the first choice for hilar cavernous hemangiomas of the liver.